World TB Day 2019: TB Patient's Contemporary Account Accepted into the Holdings of the Robert Koch Library, Berlin.

Available in print or as an audiobook on Audible and iTunes

Author: Paul Thorn

Paul Thorn's Book, Diary of a Modern Consumptive, is Accepted as Addition to Historic Library Documenting Man's Struggle Against Harmful Bacteria Since 1882.

I wonder how Dr Robert Koch, who visualised tuberculosis for the first time in 1882 would feel about our progress, nearly 140 years later?”

— Paul Thorn

BRIGHTON, EAST SUSSEX, UNITED KINGDOM, March 21, 2019 / — Diary of a Modern Consumptive by former TB patient, Paul Thorn has been accepted into the holdings of the Robert Koch Library, Robert Koch Institute, Berlin. The German doctor is considered the founder of modern bacteriology. In 1882 he visualised for the first time the bacteria that causes tuberculosis. His discoveries made a significant contribution to the development of the first chemicals developed to attack specific bacteria – he was awarded a Nobel Prize in 1905. The library collects literature in accordance with the focal work areas of the Institute. The historical stock from the time of Robert Koch is unique.

Jennifer Furin MD., PhD. of Harvard Medical School, Department of Global Health and Social Medicine, wrote the foreword for the book. She says; “The experience of this devastating illness is the subject of Paul Thorn’s riveting biography, Diary of a Modern Consumptive. In the living pages of this book, we are given a first-hand account of what it is like to live in isolation while battling with a mortal disease. It is a shattering story of the failures of modern medicine when it comes to TB. It is also, however, a miraculous memoir documenting the power of human connectedness even in the face of severe and imposed confinement.”

Both Thorn and Furin agree that the global Public Health strategy to address tuberculosis has failed.

Jennifer Furin says; “Paul’s journey is not an isolated event. Even now, millions of individuals face the same catastrophic experiences he eloquently describes. Much of shared suffering can be attributed to the way the global community has responded to the problem of TB using a public health approach. The public health approach—usually sold as a means of achieving the best results for the most people at the lowest cost—is a weapon often wielded in the war against infectious diseases. While there may be some merits to conceptualizing and responding to the world’s plagues in such a fashion, the public health approach is also incredibly dehumanizing. It sacrifices the pain of individual people on the altar of benefit to an often-abstract human mass. And to date, this public health approach to TB has failed, as seen in the dismal global statistics, the lack of new diagnostic and treatment tools, and the planned exclusion of vulnerable populations, most notably children.”

Furin continues; “There is, however, an alternative TB strategy that could finally turn the tide against this age-old scourge: a human-rights based approach to the disease. Paul provides a blueprint for such an approach in his diary, which stresses the significance of each person’s unique journey with TB. A human rights-based approach to TB means putting the person with TB at the center of all activities and striving to achieve the best possible outcome for every single man, woman, and child who is affected by the disease. It means that all people with TB – regardless of their geographic location or perceived level in society – should be offered the most sensitive diagnostic tests, be treated with the most effective medicines, be provided with all the means to prevent the development of TB, and receive care in a way that allows them to continue to live dignified and productive lives. It does not view the provision of such services as extravagant extras but rather as fundamental basics that form the core of the management of TB.

Paul Thorn says; “There’s no question in my mind that the public health strategy to address the global threat of TB has failed in most recent decades and continues to fail. I wonder how Dr Robert Koch, who visualised tuberculosis for the first time in 1882 would feel about our progress, nearly 140 years later? However, I am thrilled that my book has been accepted into this important library documenting the history of bacteriology since 1882. It’s likely to be there centuries after I’m dead and gone, this must be a milestone for any writer. A real honour.”

Thorn continues: “TB and indeed MDR-TB are treatable and curable. However, many of the older drugs have severe side effects. We live in a world where some children and adults after TB and MDR-TB treatment are left deaf, blind, psychotic, and sometimes unable to leave their homes because they require constant oxygen, but this is considered a ‘treatment success’ by the public health community because the sufferers have also been cured of TB and are therefore non-infectious to the wider population. This doesn’t have to be what ‘success’ looks like. Any strategy to deal with the problem the world faces from Mycobacterium tuberculosis needs to have its roots in a human rights-based approach, a strategy that puts a person with TB and its drug-resistant variants at the centre of all activities associated in curing it to achieve the best possible outcome for everyone.”

Diary of a Modern Consumptive by Paul Thorn is available from Amazon. It’s also available as an audiobook on Audible and iTunes.

Paul Thorn
TBpeople Global
+44 7496 665844
email us here
Visit us on social media:

“Nocturne” from Diary of a Modern Consumptive by Paul Thorn, (narrated by Adam Smith). Available on Audible and iTunes

Source: EIN Presswire

Dynamic Lower Gastroinestinals market offers growth potential

The dynamic lower GIs category is currently outperforming the consumer health market overall, according to a new report from Nicholas Hall

LONDON, GREATER LONDON, UNITED KINGDOM, UK, March 21, 2019 / — The dynamic lower GIs category – comprising laxatives, antidiarrhoeals, antispasmodics & IBS remedies, plus gut health probiotics – is currently outperforming the consumer health market overall, according to a new report from Nicholas Hall. Key growth drivers include stressful modern lifestyles and unhealthy diets leading to more GI complaints; high-profile consumer promotion (much of it educational); new product development (including new formats, increased efficacy and multi-symptom presentations); and pharmacist brand recommendations (in pharmacy-dominated markets). Probiotics form the fastest-growing category thanks to launch activity, expansion of digestive positionings and growing niche for combination products.

Looking at the forecasts, Lower GIs are set for year-on-year growth, with probiotics and antidiarrhoeals the strongest performers. Probiotics are particularly well-positioned for growth via significant scope for innovation. Positioning diversification offers one route to success; products which offer multiple health benefits (e.g. fibre supplements with cholesterol or blood sugar management benefits) look set to grow. Natural brands will be a driver in several categories, while marketers continue to invest in informative advertising and promotion to encourage self-care for digestive issues.

The full report, Lower GIs: Trends & Opportunities in Laxatives, Antidiarrhoeals, Probiotics, Antispasmodics & IBS Remedies, is available now. Full details can be found here:

For more details contact

Melissa Lee
Nicholas Hall Group of Companies
email us here
+44 1702 220200

Source: EIN Presswire

AGT Granted Fifth Patent Protecting Its Immunotherapy Cancer Cure Asset

ROCKVILLE, MD, UNITED STATES, March 21, 2019 / — American Gene Technologies (AGT) recently was awarded a fifth immuno-oncology patent (“Methods and Composition for the Activation of Gamma Delta T cells” US10137144) to protect its lead asset in immunotherapy for cancer. This patent further validates the advances AGT has made towards the treatment of cancer and infectious diseases.

The patent adds protection to AGT’s proprietary methods for activating human gamma-delta (γδ) T cells that will successfully attack a variety of solid tumors as AGT continues to obtain intellectual property surrounding its gene therapy platform for immuno-oncology.

“We are absolutely thrilled with the progress we’ve made towards developing truly novel, efficacious and well-tolerated treatments for cancers,” said Jeffrey A. Galvin, Chief Executive Officer. “These patents highlight AGT’s continued progress toward advanced treatments and cures for cancer and demonstrate the differentiation of our immuno-oncology program.”

About American Gene Technologies (AGT)

AGT is an emerging gene and cell therapy company with a platform of proprietary tools and techniques capable of broad applications including: large and orphan indications, infectious disease, immuno-oncology, and monogenic disorders. AGT expects to take its patented candidate for an HIV Cure into the clinic in 2019. It has pioneered a novel immuno-oncology approach of stimulating gamma-delta (γδ) T cells to attack a variety of cancers. Five key patents in AGT’s novel immuno-oncology approach have already been granted. In addition, AGT has a diverse portfolio of patents and patent filings surrounding key tools and components in viral vectors, gene therapy, and regenerative medicine.

Website –
LinkedIn –
Twitter –
Facebook –
Instagram –

American Gene Technologies Contacts:

C. Neil Lyons, Chief Financial Officer
Phone: (301) 337-2269

Sasha Whitaker, Digital Marketing and Communications
American Gene Technologies,
+1 301-337-2100
email us here

Source: EIN Presswire

SMi’s HPAPI 2019 Conference: Exclusive Interview Released with AstraZeneca

Highly Potent Active Pharmaceutical Ingredients Conference 2019

Highly Potent Active Pharmaceutical Ingredients Conference 2019

Highly Potential Active Pharmaceutical Ingredients Conference 2019

LONDON, UNITED KINGDOM, March 21, 2019 / — Peter Marshall from AstraZeneca will be speaking at SMi’s 3rd Annual Highly Potent Active Pharmaceutical Ingredients (HPAPI) Conference which will take place in London on 13th-14th May. He will be discussing the latest developments in the industry with a specific focus on the principles of pharmaceutical containment in isolator design. Ahead of the conference, SMi had interviewed him where he gave a taster of what he will be discussing.

Peter said:
“The HPAPI market is becoming more entrenched across the Pharma industry. Historically major pharma and some specialist contract manufacturers have led the field in design and application, but the more general toxic nature of new products has required many more companies to consider investment in contained facilities. Further to this, new drug modalities such as ADCs (antibody-drug conjugates) have presented enhanced containment challenges due to the elevated toxicity of some of the components. Finally, the toxicity of some modern inhaler and other device products has raised the importance of containment in device-related process approaches including dry powder and aseptic filling processes.”
“For me personally, the problem is often being involved in the early stages of a project to ensure that exposure control is properly considered, and optimal strategies and technologies are applied. In my opinion there are too many simplistic design or equipment selection tools which are used blindly without an understanding of their relevance and validity. In some cases these can lead to excessively conservative technology decisions which present significant operability and maintenance issues for the final user.”

The full interview is available in the Download Centre at

Key sessions to be discussed in the area of containment include – Antibody-drug conjugate manufacturing, adaptation of containment designs to cope with the high demands of HPAPIs and the challenges verifying containment performance of a HPAPI OSD facility.

Joining Peter on Day Two of the conference will be Dr Thomas Nittoli, Director, Regeneron; Dr Jeff Parry, Senior Formulation Scientist, AstraZeneca and Mr Nigel Saunders, Technical Engineer – SME Containment, GSK.

Sponsors include: BSP Pharmaceuticals | Minakem | PCi Pharma Services | SafeBridge Consultants Inc. | Solo Containment

SMi offer unique sponsorship, exhibition and branding packages, tailored to complement your company’s marketing strategy. Contact Alia Malick on Tel: +44 (0)20 7827 6168 / Email:

For media enquiries contact Neill Howard on Tel: +44 (0)20 7827 6164 / Email:

Neill Howard
SMi Group Ltd
email us here

Source: EIN Presswire

"What You Don’t Know About Laminectomy and Intervertebral Disc Removal", explained by Dr. Leonard Marchinski

Physician Profile Dr Leonard J Marchinski

Physician Profile Dr Leonard J Marchinski

Dr Leonard Marchinski, in surgery, Orthopaedic Surgeon in Pennsylvania

Dr Leonard Marchinski, in surgery, Orthopaedic Surgeon in Pennsylvania

Dr Leonard Marchinski, surgery, Orthopaedic Surgeon in Pennsylvania

Dr Leonard Marchinski, surgery, Orthopaedic Surgeon in Pennsylvania

Dr Leonard Marchinski, Orthopaedic Surgeon in Pennsylvania

Dr Leonard Marchinski, Orthopaedic Surgeon in Pennsylvania

HippocratesGuild profile Dr Leonard Joseph Marchinski

HippocratesGuild profile Dr Leonard Joseph Marchinski

Do you have questions about Effective Surgical Procedures That Relieve Back Pain? Orthopaedic Doctor Leonard Marchinski explains in his new publication.


Just like every other surgery, there are a few potential complications associated with back surgeries such as laminectomy and discectomy.”

— Dr. Leonard J. Marchinski, Pennsylvania, orthopedic surgery

WYOMISSING, PENNSYLVANIA, UNITED STATES, March 21, 2019 / — Living in the digital age, the use of digital devices like smartphones, personal computers and laptops has increased many folds from what it was, say, a decade ago. This increased usage of these devices is playing a major role in making our lifestyles sedentary. With each passing day, our bodies are paying the cost of this change. One of the major problems people face because of their inactive lifestyle is back pain.

Dr. Leonard Marchinski is providing his thoughts on this subject in a new article. The complete article will be available on Dr. Marchinski’s blog at

Constant back pain makes it difficult for people to carry out daily tasks such as walking, bending and climbing the stairs. They even find it difficult to sit in one position because of the nagging pain. Some people get rid of this pain through medicines while others have to undergo complex surgical procedures for relieving back pain. Let’s take a look at two surgical procedures that are widely used to treat back problems.


It is the process of removing the lamina – the bone that makes up the curved portion of your spinal cord. The lamina is usually removed when it starts compressing the nerves present inside the spinal cord. The compression makes it difficult for people to walk around because of terrible pain and extreme discomfort in the back, arms or legs.

The nerves are compressed because of an overgrowth inside the spinal cord. This bony overgrowth is usually a result of spinal arthritis but some people develop these overgrowths as part of the aging process.

General anesthesia is administered before back surgery. The surgeon will make a small incision on your back at the site of the bony overgrowth. They will then remove the lamina using small surgical tools. The incision will be sealed and you will be kept under observation for a few days until you fully recover from the surgery.

Intervertebral Disc Excision

Also known as discectomy, this surgical procedure is used to remove the disc that connects two adjacent vertebrae of your spinal cord. This connective disc may be removed due to a number of reasons such as continuous back pain that doesn’t subside with medication, a herniated disc, and extreme leg pain.

The doctor will inspect your spinal cord through x-ray scans to locate the intervertebral disc that’s causing trouble. You will be called in for surgery after you have cleared all the initial screening tests. General anesthesia will be administered before the surgery starts so that your body becomes numb and you do not feel anything. Next, the doctor will make a small incision on top of your backbone and remove the intervertebral disc. The incision will be sealed and you will be kept under observation until you fully recover from the surgery.

Potential Complications

Just like every other surgery, there are a few potential complications associated with back surgeries such as laminectomy and discectomy. Here is a list of the possible complications:

* Spinal nerve damage
* Development of blood clots
* Bleeding
* Infection at the surgical site
* Spinal fluid leak
* Recurring back pain

If the above-mentioned potential complications associated with back surgeries have made you nervous, here’s a fact that will ease your mind. Around 525,000 back procedures have been carried out in 2011 and that is a huge number. If there are so many people out there who have solved their back pain problem through surgery, maybe such surgery is for you! Book an appointment with your doctor to discuss the possibility of back surgery to treat the pain.

About Leonard Joseph Marchinski, MD

Dr. Leonard J. Marchinski is a medical doctor in Pennsylvania, focusing on orthopedic surgery. In addition to General Orthopedics, Dr. Marchinski provides medical and surgical treatments such as:

• Endoscopic Carpal Tunnel Release and treatment of similar Nerve Compression Syndromes
• Wrist Arthroscopy and treatment of Wrist Instability
• Reconstruction of the Base of the Thumb Joint
• Tendon and Ligament Repair, Reconstruction, Transfers
• Shoulder Replacement
• Operative and Non-Operative Fracture Care

Dr. Leonard J. Marchinski received his undergraduate education at St. Joseph’s University in Philadelphia (Biology, 1974-1977), and his Medical Degree in 1981 from The Medical College of Pennsylvania (now Drexel-Hahnemann).



Dr. Leonard J. Marchinski
+ +1 484-709-1515
email us here
Visit us on social media:

Minimally Invasive Laminectomy Surgery to Treat Lumbar Stenosis – MedStar Southern Maryland

Source: EIN Presswire

A Firenze, Lucca e Livorno la Chiesa di Scientology si batte contro la diffusione delle droghe

I volontari della Chiesa di Scientology distribuiscono opuscoli sulle droghe in Toscana

FIRENZE, TOSCANA, ITALIA, March 21, 2019 / — Lo scopo di “Un Mondo Libero dalla Droga” è quello di arrivare a informare i giovani prima che lo facciano gli spacciatori o i loro coetanei che già fanno uso di stupefacenti. Il Celebrity Centre della Città di Firenze, Chiesa di Scientology, sta da anni sostenendo “Un Mondo libero dalla Droga”, organizzando eventi pubblici e lezioni nelle scuole. A partire dal 2015 i volontari della campagna hanno tenuto lezioni a migliaia di ragazzi toscani delle scuole medie inferiori e superiori.
Gli opuscoli mettono anche in guardia sui metodi che usano gli spacciatori per diffondere le sostanze stupefacenti, proponendole come "innocue", "di moda", "curative", ecc.Gli opuscoli mettono anche in guardia sui metodi che usano gli spacciatori per diffondere le sostanze stupefacenti, proponendole come "innocue", "di moda", "curative", ecc.
Le canzoni, i film, la tv, la radio, i giornali, per non parlare di internet, sono ormai pervasi da una propaganda che tende a far percepire il consumo di certi tipi di droga come “normale”. La commercializzazione in grande stile della “Cannabis light” fa parte di questa strategia globale: far accettare l’uso di cannabis allo scopo di aver pronta una nuova generazione di clienti quando la marijuana verrà legalizzata.
Questa settimana i volontari della Chiesa hanno distribuito a Firenze, Lucca e Livorno centinaia di opuscoli informativi sui pericoli delle droghe. Negli opuscoli, destinati ai giovani e non solo, sono contenute informazioni molto dettagliate sugli effetti negativi delle sostanze stupefacenti. Lo scopo è di far sì che i giovani evitino di cadere nella trappola della droga, e magari di convincere a smettere chi ha già cominciato a farne uso.
Tutti gli opuscoli sono consultabili anche sul sito
La Chiesa di Scientology, fin dalla sua fondazione negli anni ’50 del secolo scorso, ha subito riconosciuto che la droga e l’alcol fossero una delle principali cause della spirale discendente che sta portando il pianeta alla degradazione. Il suo fondatore, L. Ron Hubbard, ha spesso condannato l’uso di droga nei suoi scritti, spiegando in dettaglio quali siano gli effetti invariabilmente negativi sul corpo e sulla mente degli individui.
“L'arma più efficace nella guerra contro la droga è l'educazione.” L. Ron Hubbard

Giovanni Trambusti
Drug Free World
+39 335 691 7711
email us here

Un mondo libero dalla droga

Source: EIN Presswire

Part 2 – Image and Branding Specialist Fotis Georgiadis Takes on Cannabis

CBD oil and Hemp plant

CBD oil and Hemp plant

Andy Wilson, the Founder and Managing Director of CBD Hemporium

Andy Wilson, the Founder and Managing Director of CBD Hemporium

Wendy Robbins & Karen Paull of The Marijuana Show

Wendy Robbins & Karen Paull of The Marijuana Show

Hemp, CBD and the Marijuana Show

Train your employees well. Make sure they love your products & find passion in educating your clients. [..] Make sure everyone shares the mission. [..] Help them find balance in their lives.”

— Wendy Robbins & Karen Paull of The Marijuana Show

GREENWICH, CT, USA, March 21, 2019 / — Fotis Georgiadis, owner of the blog by his namesake, is a branding and image consultant with a robust background and a visionary interviewer. With a knack for pulling out a well rounded interview, not only covering cutting edge technologies and corporate directions but he also brings out the personal side of the interviewee.

From personal experiences to jumping on the CBD 'gold rush', Fotis Georgiadis has captured multiple CBD journeys. In this 2nd article, we find him interviewing Andy Wilson, the Founder and Managing Director of CBD Hemporium, a company that sells organic, high-quality and lab-tested CBD products in the UK and also Wendy Robbins & Karen Paull of The Marijuana Show, a multimillion views show on Amazon Prime.

An excerpt from the interview with Andy Wilson, “I’ve been interested in alternative natural therapies and the organic and vegan movement for a long time. When a close family member became ill it became an intrinsic part of our lives. I had a friend who was involved in making cannabis oils for people with similar problems and we began to research if this was something that could benefit us. From that moment on I was engrossed in all things cannabis. Although I had been interested in cannabis from a social perspective, this new fascination was something different. I read stories of people in similar situations to us using cannabis oil to heal themselves of the most serious conditions. So with the help of a friend we incorporated a strong cannabis oil into our family member’s health regime along with a vegan organic diet with great success. We then added a CBD oil along with the cannabis oil to replace the CBD that was bred out of cannabis strains in favour of THC. In just over 12 months our family member was given a clear bill of health from their doctor.”

This is a powerful moment in the interview. We see Fotis Georgiadis really getting to the heart and soul of why Andy Wilson ran with CBD and created CBD Hemporium. The reader gets a real feel for the interviewee and a want to find out more about how CBD could help their own family and friends.

The Marijuana Show, now on Amazon Prime, was launched by Wendy and Karen while discussing potential reality show topics. This has turned into a huge success and is helping get the word out on CBD and how beneficial it can be. The journey hasn't been an easy one and Fotis Georgiadis brings this out in the interview.

“Can you share a story about the funniest mistake you made when you were first starting? Can you tell us what lesson you learned from that?

Trusting everyone. Season one of our show was shot in Denver. We had never been there and we didn’t know anyone. That all changed when we met a woman named Addison who introduced us to Dawn who introduced us to Chris who has a mansion in Cherry Creek and he let us shoot season one in his house. We had five days to shoot 10 episodes. We had a million dollars of liability insurance in case of an accident. Chris decided on the first day of the shoot that he would not let us into his house unless we had two million dollars worth of insurance. CNBC had a satellite truck outside to film our shoot and…” read the rest of the story and interview over at Fotis Georgiadis' website.

Again, bringing another success story to the masses in bit size pieces that really capture the people and business. These interviews have brought many companies into the 'limelight' and through his strong social media skill-set, extended their online presence.

In earlier interviews focused on cutting edge technologies, Fotis Georgiadis interviewed David Xing, founder and ceo of Plott. Fotis Georgiadis was thanked by David Xing for his help and interview savvy, “This was a much more personal interview than I’m used to.” You can read the whole interview with David Xing here.

This is part 2 of 2 articles on Fotis Georgiadis' visit to the cannabis world. By combining real world exposure and discussions with his social media expertise, the benefit to the CBD marketplace will be strong and far reaching. SEO, in-depth interviews, etc are all part of Fotis Georgiadis' arsenal when it comes to image and branding success. Read more about CBD and its benefits by checking out some of the books and products on Amazon.

About Fotis Georgiadis
Fotis Georgiadis is the founder of DigitalDayLab. Fotis Georgiadis is a serial entrepreneur with offices in both Malibu and New York City. He has expertise in marketing, branding and mergers & acquisitions. Fotis Georgiadis is also an accomplished VC who has successfully concluded five exits. Fotis Georgiadis is also a contributor to Authority Magazine, Thrive Global & several others


Fotis Georgiadis
Twitter: @FotisGeorgiadi3

Fotis Georgiadis
+ +1 203-983-1234
email us here
Visit us on social media:

CBD Oil Benefits for Pain, Anxiety and More (with Dr. Billy Demoss)

Source: EIN Presswire Releases the Report of Indian E-Cigarette Market Releases the Report of Indian E-Cigarette Market Releases the Report of Indian E-Cigarette Market Current Situation of E-Cigarette Market in India Current Situation of E-Cigarette Market in India

The Situation of E-Cigarette Market in India

NEW YORK, UNITED STATES, March 21, 2019 / — The Current Situation of E-Cigarette Market in India

The tobacco market of India is huge. According to the statistics of WHO, tobacco use is increasingly concentrated in low and middle income countries.

Currently, there are about 1 billion smokers worldwide, and 80% of them are from low and middle income countries.

In 2015, the top ten countries with the population of smokers outside China were Indonesia, India, Russia, the United States, Pakistan, Japan, Brazil, the Philippines, Egypt, and Mexico.

And the countries with the continuous growth of smoking population in the past five years are Indonesia, India, Pakistan, the Philippines, Egypt, Mexico, and Brazil, with an increase of around 10% except Brazil.

The number of smokers in India is second in the world, second only to China. According to the latest report of the WHO, the number of smokers aged 15 or over in India is second only to China, accounting for 106 million among the 1.1 billion smokers worldwide.

However, the Indian e-cigarette market has not yet been fully developed. Smokeless tobacco, Beedi and illegal cigarettes account for nearly 90% of tobacco sales in India.

The Development Prospects of E-Cigarettes in India

There exist several positive factors for the further development of e-cigarettes in India.

First of all, the tobacco market of India is vast. Secondly, several famous E-Cigarette companies such as Myle have already entered India. It has its own official website in India and review of Myle from India YouTubers can also be found online.

Many other vape companies plan to follow Myle's footsteps. Take JUUL as an example. JUUL has been eager to enter the Indian market, which is an important part of the company's strategy to enter Asia. India has millions of adult smokers as mentioned above, and successfully entering the Indian market can bring lucrative profits to tobacco companies Juul and Philip Morris International.

According to reliable sources, JUUL is currently studying Indian laws and regulations to enter the Indian market smoothly. In addition, JUUL will work closely with the medical community to make its products more acceptable. JUUL Labs said in a statement that India is part of its Asian market. They are evaluating the Indian market now and there is currently no “final plan”.

However, there still exist some negative factors that hinder the further development of e-cigarettes in India.

The first is fierce competition. Indian tobacco is cheap, competition in the tobacco market is fierce, and there is a huge black market.

According to a new report by ECig Intelligence, the price of tobacco cigarettes made in India is much lower than that in other countries, and smoking cigarettes in India is even cheaper than using E-Cigarettes.

The price difference between E-Cigarettes and Beedis is even greater. The Beedi is a hand-made tobacco cigarette that costs only one-eighth of the price of a regular cigarette and is the first choice for most smokers in India.

Secondly, the government banned E-Cigarettes. India’s regulation of tobacco and E-Cigarettes is extremely strict. In 2018, the Indian Ministry of Health recommended that all states stop selling or importing E-Cigarettes, claiming that “they pose a huge risk to health”.

According to the "India Times" report, the Indian National Drug Administration issued a notice saying that "manufacturing, distribution, sales, purchase, display, advertising" of E-Cigarettes are prohibited.

Six of the 29 states in India currently ban the use of E-Cigarettes. For example, Bihar. The state is the third largest state in India, located in northeastern India, southern Nepal, with a population of more than 104 million, even more than that of the United Kingdom or Germany. Bihar and five other Indian states: Jammu and Kashmir, Karnataka, Punjab, Maharashtra and Kerala have jointly banned the sale and manufacture of e-cigarette products.

E-Cigarette Shops in India

According to the Google Maps, the number of e-cigarette stores in India is still very small. Google Maps shows 54 vape shops, which are mainly concentrated in the capital New Delhi, and a small number of western coastal cities such as Mumbai in Maharashtra.

Best-selling E-cigarette Brands and Types in India

In India, the e-cigarette market is dominated by some established brands such as Joyetech, Aspire, Kangertech, Innokin, and Eleaf. Pipes and starter kits are very popular.


buy best
+86 134 8233 1184
email us here

Source: EIN Presswire

Onsite Utility Services Capital Announces Strategic Partnership with Power Cube to Give Companies More Energy Savings

DELAVAN, WISCONSIN, UNITED STATES, March 20, 2019 / — Delavan, Wisconsin and Newington, New Hampshire –Onsite Utility Services Capital, Inc. (OUS Capital) a leading provider of energy efficiency solutions for industrial and commercial businesses, and Power Cube LLC announced today a strategic partnership to integrate Power Cube’s variable frequency drive solutions with OUS Capital’s Energy Savings as a Service program.

With the variable frequency drive market surpassing annual installations of 2 million units in 2018, and anticipated to exceed $3.5 billion by 2025 (source: Global Market Insight), OUS Capital and Power Cube’s partnership places them in the perfect position to be the front runners of this continued growth.

“In the ongoing effort to keep energy costs low, companies need easier ways to become more energy-efficient, regardless of their size or industry,” said Fritz Kreiss, CEO of OUS Capital. “Together, Power Cube and OUS Capital will provide businesses nationwide with solutions that will deliver the energy efficiency results they want.”

The direct connection between Power Cube’s space-saving, eco-friendly, noiseless and long-lasting variable frequency drives and OUS Capital’s Energy Savings as a Service program allows companies nationwide to quickly lower and optimize the energy consumption used by the motors powering their heating, air conditioning, ventilation, water pumps, industrial equipment, and more – but without requiring any up front capex, and without any debt.

“Smart business executives understand the positive financial impact delivered by energy-efficient solutions,” explains Kreiss. “What has stopped so many of them from implementing those solutions in their own properties is the up-front investment requirements that can come from such a project. Energy Savings as a Service solves that problem in one simple solution, making energy efficiency easy.”

For more information about Power Cube, visit, and for more information about OUS Capital.

About Onsite Utility Services Capital
Since 1993, OUS Capital has been dedicated to unlocking the power of energy efficiency for industrial, municipal and commercial businesses nationwide through innovative solutions that lower energy consumption, reduce energy spend, and increase profits. The company’s exceptional staff of energy experts can be reached at
About Power Cube

Power Cube provides education and equipment to energy service companies, interrogators, electricians, facility managers, and more about how to identify and supply electric motor control solutions for massive energy savings. With over 40 years of direct application experience, Power Cube is exceptionally suited to deliver variable frequency drive solutions to companies of all sizes, and can be reached at

Jenna Buehre
Onsite Utility Servies Capital, LLC
+1 262-248-0926
email us here

Source: EIN Presswire

Vu360 Solutions Announces VuCare™, an Assisted Living Care Software Solution

We want our customers to be able to track all the important aspects of their business including care givers, residents/patients, equipment, and facility maintenance with ease and reliability.”

— Rizwan Khan, Founder of Vu360 Solutions

NAPERVILLE, ILLINOIS, UNITED STATES, March 20, 2019 / — Naperville, IL. – Vu360 Solutions, a leading provider of Artificial Intelligence (AI), Machine Learning (ML) and IoT based software solutions, is pleased to announce VuCare™ a complete end-to-end solution for assisted living care and nursing home facilities. The AI and IoT powered VuCare solution provides facility operators with advanced tools that offer world class services to their residents/clients while improving overall facility efficiency, performance and reduced operating cost.

The VuCare software provides staff with a variety of support modules such as: Medication Tracking, Patient Information, Patient Tracking, Laundry, Asset and Personnel Tracking, Lead/Referral Management and Patient Billing.

Not only does VuCare provide a supportive structure for easier patient care, but our software also integrates with legacy healthcare and financial management programs. We connect care services, billing and administrative functions across a single, cloud-based platform.

To learn more about VuCare visit our website or email us at

About Vu360 Solutions
Vu360 Solutions is the fastest growing global software technology company that utilizes IoT and AI/Machine Learning technologies to enable companies to use continuous intelligence to solve complex problems, improve overall efficiency and enhance profitability. To learn more about Vu360 Solutions visit our website

Micalina Grove
Vu360 Solutions
+1 630-233-4471
email us here
Visit us on social media:

Source: EIN Presswire